Cargando…
Mechanistic Insights into the Anti-angiogenic Activity of Trypanosoma cruzi Protein 21 and its Potential Impact on the Onset of Chagasic Cardiomyopathy
Chronic chagasic cardiomyopathy (CCC) is arguably the most important form of the Chagas Disease, caused by the intracellular protozoan Trypanosoma cruzi; it is estimated that 10–30% of chronic patients develop this clinical manifestation. The most common and severe form of CCC can be related to vent...
Autores principales: | Teixeira, Samuel Cota, Lopes, Daiana Silva, Gimenes, Sarah Natalie Cirilo, Teixeira, Thaise Lara, da Silva, Marcelo Santos, Brígido, Rebecca Tavares e Silva, da Luz, Felipe Andrés Cordero, da Silva, Aline Alves, Silva, Makswell Almeida, Florentino, Pilar Veras, Tavares, Paula Cristina Brígido, dos Santos, Marlus Alves, Ávila, Veridiana de Melo Rodrigues, Silva, Marcelo José Barbosa, Elias, Maria Carolina, Mortara, Renato Arruda, da Silva, Claudio Vieira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359584/ https://www.ncbi.nlm.nih.gov/pubmed/28322302 http://dx.doi.org/10.1038/srep44978 |
Ejemplares similares
-
Trypanosoma cruzi P21: a potential novel target for chagasic cardiomyopathy therapy
por: Teixeira, Thaise Lara, et al.
Publicado: (2015) -
Galectin-3: A Friend but Not a Foe during Trypanosoma cruzi Experimental Infection
por: da Silva, Aline A., et al.
Publicado: (2017) -
The Recombinant Form of Trypanosoma cruzi P21 Controls Infection by Modulating Host Immune Response
por: Martins, Flávia Alves, et al.
Publicado: (2020) -
A successful strategy for the recovering of active P21, an insoluble recombinant protein of Trypanosoma cruzi
por: Santos, Marlus Alves dos, et al.
Publicado: (2014) -
The Recombinant Protein Based on Trypanosoma cruzi P21 Interacts With CXCR4 Receptor and Abrogates the Invasive Phenotype of Human Breast Cancer Cells
por: Borges, Bruna Cristina, et al.
Publicado: (2020)